Accurate results
for patient care
Laboratory medicine and in vitro diagnostics

JCTLM Database: higher-order reference materials, methods and services

Details : C12RMP1 - 2D-UPLC-tandem mass spectrometric method for analysis of amyloid beta 1-42 in human CSF

Type (acronym)rmp
Typereference measurement procedure
Unique Nomination NumberC12RMP1
Analyte Nameamyloid beta 1-42
IUPAC IFCC NumberAmyloid Beta 1-42
Method capable of Traceability of Analyte to SI or Defined ProcedureSI
Applicable Matricesfrozen human cerebrospinal fluid (CSF)
Name2D-UPLC-tandem mass spectrometric method for analysis of amyloid beta 1-42 in human CSF
Organization that developed Validated MethodBiomarker Research Laboratory of Perelman School of Medicine, University of Pennsylvania
Measurement Techniques UsedLiquid chromatography tandem mass spectrometry, solid phase extraction
QuantityMass concentration
From (0)100
To (0)3000
Unit (0)pg/mL
From (1)14.3
To (1)355.2
Unit (1)pg/mL
Level of Confidence (%)95%
Peer Reviewed PublicationQualification of a surrogate matrix-based absolute quantification method for Amyloid β42 in human cerebrospinal fluid using 2D UPLC-Tandem Mass Spectrometry, Korecka M et al., ''Journal of Alzheimer's Disease (JAD)'', 2014, 41(2), 441-451
Comments to be published via JCTLM DBThe reference measurement method, C12RMP1, for quantification of Aβ42 in cerebrospinal fluid was developed and validated by the Biomarker Research Laboratory of Perelman School of Medicine, University of Pennsylvania
Review Team Nameproteins
Analyte Category NameProteins
Non-CCQM Key Comparison ReportClinical comparison with immunoassay as cited in: Korecka M et al., JAD, 2014, 41(2), 441-451
Non-CCQM Key Comparison Report Hyperlink
Non-CCQM Key Comparison ReportRound robin test on quantification of amyloid-β-1-42 in cerebrospinal fluid by mass spectrometry, Pannee J et al., ''Alzheimer's and Dementia'', 2016, 12(1), 55-59
Non-CCQM Key Comparison Report Hyperlink
Measurement principle/techniqueIsotope dilution mass spectrometry